An intranasal nanoparticle STING agonist has broad protective immunity against respiratory viruses and variants
A. Leekha, A. Saeedi, M. Kumar, S. R. Sefat, M. M. Paniagua, M. Fathi, R. Kulkarni, S. Biswas, D. Tsitoura, X. Liu, L. J. N. Cooper, M. Sebastian, B. L. Hurst, N. Varadarajan
This study develops NanoSTING, an intranasal nanoparticle STING agonist, showing broad protection against respiratory viruses and variants in animal models.
bioRxiv · Apr 18, 2022Immunology